GC twitted about giving info on Monday regarding an ideal platform to reveal Phase 2 results (to get max investor exposure). That may be true. My guess would be it's been postponed again for sometime in Feb. I think the fact that deal with NLC Pharma has not been finalized/announced yet could be behind this cat & mouse game. On a positive note, the company surely knows the results by now and is sending the signal that they are good.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links